JPRN-UMIN000042934已完成未知
Inhibitory Effect of Abatacept against Joint Inflammation Shown by Ultrasound Power Doppler Scoring in Japanese Bio-Naive Patients with Rheumatoid Arthritis - SAKURA STUDY
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 21
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Patients who are suffering from severe infectious disease. 2.Patients with lymphocytes less than 500/microL and high levels of beta-D glucan 3.Patients who are infected EB virus or HBV 4.Patients who are unsuitable to participate in this study by attending physicians.
研究者
相似试验
进行中（未招募）
1 期
Abatacept reversing subclinical Inflammation as measured by MRI in ACPA positive ArthralgiaEUCTR2014-000555-93-ESniversitätsklinikum Erlangen98
进行中（未招募）
1 期
Abatacept reversing subclinical Inflammation as measured by MRI in ACPA positive ArthralgiaPatients with ACPA (anti citrullinated peptide antibodies) positive arthralgia and OMERACT RAMRIS synovitis (synovialitis or tenosynovitis) or osteitis but without clinical arthritis, defined by joint swellingMedDRA version: 20.0Level: PTClassification code 10003239Term: ArthralgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2014-000555-93-CZniversity Hospital Erlangen98
进行中（未招募）
1 期
Abatacept reversing subclinical Inflammation as measured by MRI in ACPA positive ArthralgiaPatients with ACPA (anti citrullinated peptide antibodies) positive arthralgia and OMERACT RAMRIS synovitis (synovialitis or tenosynovitis) or osteitis but without clinical arthritis, defined by joint swellingMedDRA version: 20.0Level: PTClassification code 10003239Term: ArthralgiaSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersEUCTR2014-000555-93-DEniversity Hospital Erlangen98
招募中
不适用
Investigation of the Effects of Abatacept on Rheumatoid Arthritis: Analysis of Efficacy on Arthritis and AtherosclerosisRheumatoid ArthritisJPRN-UMIN000014913Department of Internal Medicine, Toho University280
已完成
2 期
Safety of Abatacept in patients with interstitial lung disease and Common variable immunodeficiency (CVID) and related diseaseD83.9J84.9Common variable immunodeficiency, unspecifiedInterstitial pulmonary disease, unspecifiedDRKS00008783niversitätsklinikum Freiburg10